0
0.5
1
1.5
2+
Time to improvement
37%
Improvement
Relative Risk
Time to improvement (b)
59%
Favipiravir Shinkai et al. LATE TREATMENT RCT
Is late treatment with favipiravir beneficial for COVID-19?
RCT 156 patients in Japan
Faster recovery with favipiravir (p=0.014)
c19early.org
Shinkai et al., Infectious Diseases an.., Aug 2021
Favors favipiravir
Favors control